Scholarlink

<p>Immunoglobulins (Ig) are essential for protection against invading pneumococci but are not routinely analyzed in patients with invasive pneumococcal disease (IPD). In this prospective study, we assessed the prevalence of monoclonal Ig (M protein) and analyzed Ig concentrations in sera from 156 adult IPD patients (median age 70 years). Patients were sampled during acute infection (<i>n</i> = 153) and in the convalescence phase 2–4 months after acute infection (<i>n</i> = 76). Sixty-four sex- and age-matched individuals without IPD served as controls. During infection, M protein was detected in 22% (31/141) of patients without previously known hematological malignancy as compared with 5% of the controls (<i>p</i> = 0.002). Seven of these patients were subsequently diagnosed with a hematological malignancy, including multiple myeloma, Waldenstrom macroglobulinemia, and mantle cell lymphoma. Another 12 patients were diagnosed with monoclonal gammopathy of undetermined significance (MGUS). Convalescence levels of IgA, IgG2, or IgG4 were below the reference intervals in 16–20% of patients and 0–2% of controls. Three patients were diagnosed with a primary Ig deficiency, and seven patients started Ig replacement therapy. Our findings suggest that assessment of M protein and Ig levels could be considered in adults with IPD, as an episode of IPD may unmask a previously undiagnosed B-cell malignancy or immunodeficiency.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Invasive pneumococcal disease unmasks monoclonal immunoglobulins and antibody deficiencies: a multicenter prospective study in adults

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月24日

查看全文
  • Tor Härnqvist,
  • Karin Bergman,
  • Åsa Mellgren,
  • Magnus Brink,
  • Amanda Nilsson,
  • Staffan Nilsson,
  • Bengt Andersson,
  • Rune Andersson,
  • Anna Lundgren,
  • Johanna Karlsson,
  • Susann Skovbjerg

摘要

Immunoglobulins (Ig) are essential for protection against invading pneumococci but are not routinely analyzed in patients with invasive pneumococcal disease (IPD). In this prospective study, we assessed the prevalence of monoclonal Ig (M protein) and analyzed Ig concentrations in sera from 156 adult IPD patients (median age 70 years). Patients were sampled during acute infection (n = 153) and in the convalescence phase 2–4 months after acute infection (n = 76). Sixty-four sex- and age-matched individuals without IPD served as controls. During infection, M protein was detected in 22% (31/141) of patients without previously known hematological malignancy as compared with 5% of the controls (p = 0.002). Seven of these patients were subsequently diagnosed with a hematological malignancy, including multiple myeloma, Waldenstrom macroglobulinemia, and mantle cell lymphoma. Another 12 patients were diagnosed with monoclonal gammopathy of undetermined significance (MGUS). Convalescence levels of IgA, IgG2, or IgG4 were below the reference intervals in 16–20% of patients and 0–2% of controls. Three patients were diagnosed with a primary Ig deficiency, and seven patients started Ig replacement therapy. Our findings suggest that assessment of M protein and Ig levels could be considered in adults with IPD, as an episode of IPD may unmask a previously undiagnosed B-cell malignancy or immunodeficiency.